IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Xeris Pharmaceuticals Inc

CUSIP: 98422L107 | 195 institutional holders

Quarters

Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2022

Investment Research & Advisory Group, Inc.803
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Investment Research & Advisory Group, Inc.
803$10.0%GrowthVery LowAtlanta, GA2022-07-19